Dannex Ayrton Starwin Plc (GHSE:DASPHARMA)

Market Cap	32.21M
Revenue	n/a
Net Income	n/a
Shares Out	84.77M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18
Average Volume	2,956
Open	n/a
Previous Close	0.3800
Day's Range	n/a
52-Week Range	0.3800 - 0.3800
Beta	-0.02
RSI	49.74
Earnings Date	n/a

About Dannex Ayrton Starwin

Dannex Ayrton Starwin Plc manufactures and sells pharmaceutical products in Ghana. It offers a range of products in various categories, such as analgesics and antipyretics, hematinics, anti-tussives, anti-convulsing and anti-asthmatics, cough preparations, dermatological products, food supplements, vitamins, and minerals. The company manufactures its products in form of syrups, tablets, creams, suspensions, disinfectants, lozenges, powders, capsules, and emulsions. It provides its products under the Durol, Virol, Samalin, Teeder, Koffex, ORS, R...

• Industry: Pharmaceutical Preparations
• Founded: 1964
• Employees: 83
• Stock Exchange: Ghana Stock Exchange
• Ticker Symbol: DASPHARMA